Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Business Times.
Press releases published on May 13, 2025
Best Crypto Casinos Canada: Find Out The Top Canadian Crypto Casino Of 2025! – By Jackbit Casinos
GlobeNewswire
·
May 13, 2025
TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- After evaluating several options using strict criteria, our expert team identified the best crypto casinos in Canada. By analyzing game variety, bonuses, security features, and overall user experience, we’ve …
Y-mAbs to Host Virtual Radiopharmaceutical R&D Update on May 28, 2025
GlobeNewswire
·
May 13, 2025
PRINCETON, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody- …
Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
May 13, 2025
Company Seeking Conditional Approval from European Medicines Agency (EMA) for Iopofosine I 131 in Waldenstrom Macroglobulinemia based upon CLOVER WaM Phase 2 Study Data CLOVER WaM Major Response Rate for BTKi-Treated Patients 59.0% Company to hold webcast …
Invivyd to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
GlobeNewswire
·
May 13, 2025
WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20, 2025, at 11:00 a.m. ET in …
Rogers Sugar Inc. Declares Dividend to Shareholders
GlobeNewswire
·
May 13, 2025
THIS MEDIA RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (RSI) announces that its Board of Directors has authorized a …
Rogers Sugar Inc. déclare un dividende aux actionnaires
GlobeNewswire
·
May 13, 2025
LE PRÉSENT COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE DISSÉMINATION DES ÉTATS-UNIS NI ÊTRE PUBLIÉ AUX ÉTATS-UNIS MONTRÉAL, 13 mai 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (RSI) annonce que son Conseil d’administration a autorisé la …
Editas Medicine Reports New In Vivo Proof of Concept Data in an Undisclosed Liver Target at the American Society of Gene and Cell Therapy Annual Meeting
GlobeNewswire
·
May 13, 2025
In vivo CRISPR Editing Results in Functional Upregulation of a Liver Target Protein and Meaningful Reduction of Disease-Associated Biomarker in Mice CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene …
Rogers Sugar Delivers Solid Second Quarter Results, with Record Performance from Maple Segment
GlobeNewswire
·
May 13, 2025
VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (the “Company”, “Rogers”, “RSI” or “our,” “we”, “us”) (TSX: RSI) today reported results for the second quarter and first six months of fiscal 2025. Consolidated adjusted EBITDA …
Rogers Sugar annonce des résultats solides pour le deuxième trimestre et un rendement sans précédent du secteur des produits de l’érable
GlobeNewswire
·
May 13, 2025
VANCOUVER, Colombie-Britannique, 13 mai 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (la « Société », « Rogers », « RSI », « notre », « nos », « nous ») (TSX : RSI) présente aujourd’hui ses résultats du deuxième trimestre et du premier semestre de l’exercice …
Instil Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 13, 2025
Enrollment of 1L NSCLC patients in China trial of AXN-2510/IMM2510 in combination with chemotherapy is ongoing with initial clinical data by ImmuneOnco expected in 2H 2025 Initiation of U.S. clinical study of AXN-2510/IMM2510 in combination with …
Orchard Therapeutics Announces New England Journal of Medicine Publication of Long-term Clinical Outcomes from its HSC Gene Therapy for MLD and Multiple Presentations at ASGCT 2025
GlobeNewswire
·
May 13, 2025
LENMELDY™ is the first and only disease-modifying intravenous infusion proven to extend life expectancy in pre-symptomatic late infantile (PSLI) patients and mitigate the cognitive and/or physical impact of early-onset MLD Six accepted abstracts at ASGCT …
Bilibili Inc. Announces Repurchase Right Notification for 1.25% Convertible Senior Notes due 2027
GlobeNewswire
·
May 13, 2025
SHANGHAI, May 13, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it is notifying holders of its 1.25% …
Immatics Announces First Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
May 13, 2025
IMA203 PRAME Cell Therapy: Randomized-controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing and expected to complete enrollment in 2026 IMA203 PRAME Cell Therapy: Phase 1b clinical trial ongoing with updated data in metastatic …
Gauzy Ltd. Announces First Quarter 2025 Results
GlobeNewswire
·
May 13, 2025
Strong Demand and Backlog Growth Continued into 2025 Launches Serial Production for GM’s Cadillac Celestiq SPD Rooftop Expands Gross Margins, Highlighting the Benefits of Scale and Operational Improvements Reaffirms 2025 Guidance of Healthy Double-Digit …
Digital Science to support U.S. government libraries through new FEDLINK partnership
GlobeNewswire
·
May 13, 2025
LONDON and CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Digital Science, a technology company serving stakeholders across the research ecosystem, will offer U.S. government libraries access to some of its most powerful research data and analytics …
Beam Therapeutics to Participate in 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
·
May 13, 2025
CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that management will participate in a fireside chat at the 2025 …
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
GlobeNewswire
·
May 13, 2025
Treated first FTD-GRN patient with Dose 2 PBFT02 and enrolled second patient; several additional patients being evaluated for trial eligibility Announced presentation of process development data of a high productivity, suspension-based manufacturing …
Farmers of Salem Proudly Spotlights Breast Cancer Survivor and Employee, Loraine Lester, for Her Generous Charitable Giving Work
GlobeNewswire
·
May 13, 2025
WILMINGTON, Del., May 13, 2025 (GLOBE NEWSWIRE) -- Farmers of Salem, a regional mutual insurance company specializing in insurance for home and business owners, is proud to support employee involvement in charitable activities that improve the quality of …
Iterum Therapeutics Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 13, 2025
--Preparing for Potential Launch of ORLYNVAHTM by Q4 2025-- --Extended Cash Runway into 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a …
Climb Channel Solutions Promotes Carlos Rodrigues to President of North America
GlobeNewswire
·
May 13, 2025
EATONTOWN, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions (Climb), an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is pleased to announce the promotion of Carlos …